No-touch technique in liver transplant for liver cancer
Part of Cancer, Digestive system clinical trials.
This study tests a special surgical method during liver transplant that avoids touching the tumor directly, which may help reduce the chance of cancer returning. It is for people with liver cancer who are getting a deceased donor liver transplant for the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cancer (hepatocellular carcinoma) based on imaging (CT or MRI) or a biopsy.
- You are scheduled to receive a liver transplant from a deceased donor for the first time.
- You are not having a split liver transplant or a transplant of more than one organ at the same time.
- You are not having a repeat liver transplant.
- Your cancer has not spread into the major blood vessels of the liver (such as the portal vein).
- You will be able to complete follow-up visits and have complete medical records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at whether a liver transplant can help people who have liver cancer that has spread into the bile ducts, which are the tubes that carry bile from the liver. We want to see if this surgery is safe and how well it works for these patients.
This trial tests a new way to treat liver cancer by first transplanting part of a donor liver while keeping most of the original liver, then removing the remaining cancer later. It may help patients with liver cancer who need a transplant but have limited options.
This study looks at whether combining different liver-directed treatments with newer cancer drugs can help people with liver cancer who are waiting for a liver transplant. It aims to see if these treatments are safe and helpful for a wider group of patients.
This trial studies how a whole-body PET/CT scan using a “tracer” called 18F-FDG can help decide which people with liver cancer (HCC) may benefit from a liver transplant. It may help the transplant team better sort out who is likely to do well after transplant.
This trial tests whether giving chemotherapy directly into the liver blood supply before a liver transplant can help people with liver cancer that is beyond standard transplant criteria. It may help lower cancer risk around the time of transplant while keeping people healthy enough to receive the transplant.
This trial tests an immunotherapy “downstaging” plan to shrink hepatocellular carcinoma (a type of liver cancer) so it may become treatable with a liver transplant. You may be eligible if your cancer is beyond transplant limits but is still only in the liver, and you meet specific liver function and health requirements.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.